Ticker Scorecard - IBRX Basics Company: ImmunityBio, Inc. Common Stock IPO Date: July 27, 2015 Sector: Healthcare Industry: Biotech Market Cap: $2.5B Activated in VL: True Average Daily Range Avg Daily Range: $0.28 | 4.67% Avg Daily Range (30 D): $0.15 | 4.98% Avg Daily Range (90 D): $0.18 | 4.70% Institutional Daily Volume Avg Daily Volume: 2.89M Avg Daily Volume (30 D): 6M Avg Daily Volume (90 D): 6.2M Trade Size Avg Trade Size (Sh.): 186 Avg Trade Size (Sh.) (30 D): 272 Avg Trade Size (Sh.) (90 D): 256 Institutional Trades Total Inst.Trades: 1,008 Avg Inst. Trade: $1.88M Avg Inst. Trade (30 D): $1.17M Avg Inst. Trade (90 D): $1.57M Avg Inst. Trade Volume: .32M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.01M Avg Closing Trade (30 D): $.9M Avg Closing Trade (90 D): $1.18M Avg Closing Volume: 332.45K     News Aug 23, 2024 @ 8:30 PM HCW Biologics Reports Second Quarter 2024 Financia... Source: N/A Jun 26, 2024 @ 1:41 PM ImmunityBio (IBRX) Gains 17% in the Past Week: Her... Source: Zacks Equity Research Mar 20, 2024 @ 3:41 PM Sportradar Group Posts Upbeat Earnings, Joins King... Source: Avi Kapoor Feb 26, 2024 @ 6:57 PM Why Freshpet Shares Are Trading Higher By Around 1... Source: Avi Kapoor Feb 26, 2024 @ 1:18 PM Why Intuitive Machines Shares Are Trading Lower By... Source: Avi Kapoor Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.12 $-.2 $-.2 Diluted EPS $-.14 $-.2 $-.2 Revenue $ 6.11M $ 1.05M $ .04M Gross Profit $ $ $ Net Income / Loss $ -85.75M $ -134.58M $ -134.13M Operating Income / Loss $ -80.25M $ -99.33M $ -95.2M Cost of Revenue $ M $ M $ M Net Cash Flow $ -18.15M $ -2.94M $ -132.38M PE Ratio